Close Menu

NextGen Sciences

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

Movers & Shakers

Premium

Glenn Barney, Dario Alessi, Philip Cohen, Stephane Bancel, Noubar Afeyan

New Products

Premium

Agilent, Thermo Fisher Scientific, Waters, NextGen Sciences, Protea Biosciences, Origene

New Products

Premium

NanoInk, Integromics, NextGen Sciences, Avantra Biosciences, ProImmune

The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.

The bump in revenues comes amid a shift in the company's business model during 2010 to focus on "higher value, scalable projects."

With the deal, Myriad will acquire RBM's biomarker discovery platform as well as its pipeline of proprietary protein biomarker-based diagnostics, including two tests that a Myriad official said were "relatively close to commercial launch."

New Products

Premium

Olink Bioscience, NextGen Sciences, Sage-N Research, Origene

Pages

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.